Imagion Biosystems Limited (ASX:IBX)
Australia · Delayed Price · Currency is AUD 0.0080
0.00 (0.00%)
Sep 7, 2026, 9:59 AM AEST
Imagion Biosystems Income Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.57 | 0.07 | 2.67 | 4.97 | 3.07 | 2.86 | |
Revenue Growth | -45.71% | -97.26% | -46.38% | 61.87% | 7.54% | 5.88% |
Cost of Revenue | 3.08 | 2.1 | 0.4 | 5.25 | 3.62 | 2.7 |
Gross Profit | -2.51 | -2.03 | 2.26 | -0.28 | -0.54 | 0.15 |
Selling, General & Admin | 1.61 | 1.47 | 2.62 | 10.28 | 7.98 | 5.76 |
Operating Expenses | 1.6 | 1.48 | 3.01 | 11.47 | 9.09 | 6.17 |
Operating Income | -4.1 | -3.51 | -0.75 | -11.75 | -9.63 | -6.01 |
Interest Expense | -0.54 | -0.85 | -1.14 | -0.92 | -0.17 | -0.01 |
Currency Exchange Gain (Loss) | -0 | -0 | 0 | -0.01 | -0 | -0 |
Other Non Operating Income (Expenses) | 0.02 | 0.05 | -0.18 | 0.2 | - | - |
Pretax Income | -4.63 | -4.31 | -2.07 | -12.47 | -9.81 | -6.02 |
Net Income | -4.63 | -4.31 | -2.07 | -12.47 | -9.81 | -6.02 |
Net Income to Common | -4.63 | -4.31 | -2.07 | -12.47 | -9.81 | -6.02 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 422 | 277 | 45 | 30 | 28 | 26 |
Shares Outstanding (Diluted) | 422 | 277 | 45 | 30 | 28 | 26 |
Shares Change | 226.41% | 517.31% | 47.45% | 8.75% | 7.04% | 40.22% |
EPS (Basic) | -0.01 | -0.02 | -0.05 | -0.41 | -0.35 | -0.23 |
EPS (Diluted) | -0.01 | -0.02 | -0.05 | -0.41 | -0.35 | -0.24 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -4.05 | -4.04 | -1.27 | -8.51 | -8.58 | -5.29 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.03 | -0.28 | -0.31 | -0.20 |
Gross Margin | - | - | 84.95% | -5.63% | -17.75% | 5.31% |
Operating Margin | -715.80% | -4808.73% | -28.05% | -236.32% | -313.63% | -210.64% |
Profit Margin | -807.56% | -5900.86% | -77.55% | -250.95% | -319.36% | -210.98% |
Free Cash Flow Margin | -706.97% | -5536.97% | -47.67% | -171.13% | -279.44% | -185.16% |
EBITDA | -4.1 | -3.5 | -0.7 | -11.59 | -9.49 | -5.9 |
EBITDA Margin | - | - | -26.27% | -233.12% | - | -206.47% |
D&A For EBITDA | 0.01 | 0.01 | 0.05 | 0.16 | 0.14 | 0.12 |
EBIT | -4.1 | -3.51 | -0.75 | -11.75 | -9.63 | -6.01 |
EBIT Margin | - | - | -28.05% | -236.32% | - | -210.64% |
Revenue as Reported | 0.07 | 0.07 | 2.67 | 4.97 | 3.07 | 2.86 |